drug · small molecule
ESTRING
updated 6mo ago/ ES-trə-DY-ohl /
by $PFE PFIZER INC🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval204 co-mentions · 63 sources
- drugNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE76 co-mentions · 18 sources
- drugNORGESTIMATE AND ETHINYL ESTRADIOL71 co-mentions · 18 sources
- drugDAYSEE62 co-mentions · 18 sources
- tagSmall Molecule52 co-mentions · 37 sources
- drugnorethindrone21 co-mentions · 13 sources
- tagRecall13 co-mentions · 12 sources
- drugORIAHNN (COPACKAGED)10 co-mentions · 5 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 12 approved and 41 investigational indications.
targets
Estrogen receptor
all catalysts(0)
nothing on the calendar yet
Trials studying ESTRING
- phase1A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female Participants
- phase3Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA)
- phase1A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects
- phase1A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies
- phase1A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants
- phase1Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)
- phase1A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- phase3The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial
News(1)
- FDA Approves Once-Weekly Generic Hormone Therapy Patch for WomenToday, the U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy pa…fda_press · 27d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that